Noninvasive Diagnosis of Clinically Significant Portal Hypertension in Patients With Compensated Liver Disease: Whom and How to Screen?

Affiliations

Comment

Sanchit Sharma et al. Am J Gastroenterol. 2021.

. 2021 May 1;116(5):1096-1097.

doi: 10.14309/ajg.0000000000001078.

¹ Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi, India.

No abstract available

Comment on

Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease.
Pons M, Augustin S, Scheiner B, Guillaume M, Rosselli M, Rodrigues SG, Stefanescu H, Ma MM, Mandorfer M, Mergeay-Fabre M, Procopet B, Schwabl P, Ferlitsch A, Semmler G, Berzigotti A, Tsochatzis E, Bureau C, Reiberger T, Bosch J, Abraldes JG, Genescà J. Pons M, et al. Am J Gastroenterol. 2021 Apr;116(4):723-732. doi: 10.14309/ajg.0000000000000994. Am J Gastroenterol. 2021. PMID: 33982942

1. Pons M, Augustin S, Scheiner B, et al. Noninvasive diagnosis of portal hypertension in patients with compensated advanced chronic liver disease. Am J Gastroenterol 2020;116(4):723–32.
1. Lens S, Baiges A, Alvarado-Tapias E, et al. Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension. J Hepatol 2020. doi: 10.1016/j.jhep.2020.05.050 . - DOI
1. Jindal A, Bhardwaj A, Kumar G, Sarin SK. Clinical decompensation and outcomes in patients with compensated cirrhosis and hepatic venous pressure gradient ≥20 mm Hg. Am J Gastroenterol 2020;115(10):1624–1633.